Clinical Trials Browser

Phase 1 × OTHER × Leukemia, T-Cell × Clear all

NCT03829540 2026-01-22

CD4CAR for CD4+ Leukemia and Lymphoma

Phase 1 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, T-Cell, Lymphoma, T-Cell

NCT06934382 2025-12-26

24CT015

Phase 1 Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Leukemia, T-Cell, Lymphoma, T-Cell, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT04840875 2024-11-14

Phase I Clinical Trial of Autologous CD7-CAR T Cell Therapy for High-risk Acute T-cell Leukemia/lymphoma

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, T-Cell, Lymphoma, T-Cell

NCT04219319 2022-08-16

LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T-cell Lymphoma

Phase 1 Terminated

LymphoidOther hematologic neoplasm

Leukemia, T-Cell, Lymphoma, T-Cell

NCT04973527 2022-08-16

LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T Lymphocyte Tumor

Phase 1 Terminated

LymphoidOther hematologic neoplasm

Leukemia, T-Cell, Lymphoma, T-Cell

NCT04823091 2022-03-16

Anti-CD7 CAR-Engineered T Cells for T Lymphoid Malignancies Malignancies

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, T-Cell, Leukemia, Prolymphocytic, T-Cell, Lymphoma, T-Cell